Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants

IF 2 Q4 VIROLOGY
Shuntai Zhou, Nathan Long, Ronald Swanstrom
{"title":"Evolution driven by a varying host environment selects for distinct HIV-1 entry phenotypes and other informative variants","authors":"Shuntai Zhou, Nathan Long, Ronald Swanstrom","doi":"10.3389/fviro.2023.1291996","DOIUrl":null,"url":null,"abstract":"<p>HIV-1 generates remarkable intra- and inter-host viral diversity during infection. In the response to the dynamic selective pressures of the host’s environment, HIV-1 evolves distinct phenotypes—biological features that provide fitness advantages. The transmitted form of HIV-1 has been shown to require a high density of CD4 on the target cell surface (as found on CD4<sup>+</sup> T cells) and typically uses C–C chemokine receptor type 5 (CCR5) as a coreceptor during entry. This phenotype is referred to as R5T cell-tropic (or R5 T-tropic); however, HIV-1 can switch to a secondary coreceptor, C–X–C chemokine receptor type 4 (CXCR4), resulting in a X4T cell-tropic phenotype. Macrophage-tropic (or M-tropic) HIV-1 can evolve to efficiently enter cells expressing low densities of CD4 on their surface (such as macrophages/microglia). So far only CCR5-using M-tropic viruses have been found. M-tropic HIV-1 is most frequently found within the central nervous system (CNS), and infection of the CNS has been associated with neurologic impairment. It has been shown that interferon-resistant phenotypes have a selective advantage during transmission, but the underlying mechanism of this is still unclear. During untreated infection, HIV-1 evolves under selective pressure from both the humoral/antibody response and CD8<sup>+</sup> T-cell killing. Sufficiently potent antiviral therapy can suppress viral replication, but if the antiviral drugs are not powerful enough to stop replication, then the replicating virus will evolve drug resistance. HIV-1 phenotypes are highly relevant to treatment efforts, clinical outcomes, vaccine studies, and cure strategies. Therefore, it is critical to understand the dynamics of the host environment that drive these phenotypes and how they affect HIV-1 pathogenesis. This review will provide a comprehensive discussion of HIV-1 entry and transmission, and drug-resistant phenotypes. Finally, we will assess the methods used in previous and current research to characterize these phenotypes.</p>","PeriodicalId":73114,"journal":{"name":"Frontiers in virology","volume":"42 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in virology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fviro.2023.1291996","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

HIV-1 generates remarkable intra- and inter-host viral diversity during infection. In the response to the dynamic selective pressures of the host’s environment, HIV-1 evolves distinct phenotypes—biological features that provide fitness advantages. The transmitted form of HIV-1 has been shown to require a high density of CD4 on the target cell surface (as found on CD4+ T cells) and typically uses C–C chemokine receptor type 5 (CCR5) as a coreceptor during entry. This phenotype is referred to as R5T cell-tropic (or R5 T-tropic); however, HIV-1 can switch to a secondary coreceptor, C–X–C chemokine receptor type 4 (CXCR4), resulting in a X4T cell-tropic phenotype. Macrophage-tropic (or M-tropic) HIV-1 can evolve to efficiently enter cells expressing low densities of CD4 on their surface (such as macrophages/microglia). So far only CCR5-using M-tropic viruses have been found. M-tropic HIV-1 is most frequently found within the central nervous system (CNS), and infection of the CNS has been associated with neurologic impairment. It has been shown that interferon-resistant phenotypes have a selective advantage during transmission, but the underlying mechanism of this is still unclear. During untreated infection, HIV-1 evolves under selective pressure from both the humoral/antibody response and CD8+ T-cell killing. Sufficiently potent antiviral therapy can suppress viral replication, but if the antiviral drugs are not powerful enough to stop replication, then the replicating virus will evolve drug resistance. HIV-1 phenotypes are highly relevant to treatment efforts, clinical outcomes, vaccine studies, and cure strategies. Therefore, it is critical to understand the dynamics of the host environment that drive these phenotypes and how they affect HIV-1 pathogenesis. This review will provide a comprehensive discussion of HIV-1 entry and transmission, and drug-resistant phenotypes. Finally, we will assess the methods used in previous and current research to characterize these phenotypes.

由不同宿主环境驱动的进化选择了不同的HIV-1进入表型和其他信息变体
HIV-1在感染过程中产生显著的宿主内和宿主间病毒多样性。在对宿主环境的动态选择压力的反应中,HIV-1进化出独特的表型-提供适应性优势的生物学特征。HIV-1的传播形式已被证明需要靶细胞表面高密度的CD4(如在CD4+ T细胞上发现的),并且通常在进入时使用C-C趋化因子受体5型(CCR5)作为辅助受体。这种表型被称为R5T细胞嗜性(或R5 t嗜性);然而,HIV-1可以转换为次级辅助受体,C-X-C趋化因子受体4型(CXCR4),导致X4T细胞表型。嗜巨噬细胞(或嗜m型)HIV-1可以进化到有效地进入表面表达低密度CD4的细胞(如巨噬细胞/小胶质细胞)。到目前为止,只发现了使用ccr5的嗜m型病毒。嗜m型HIV-1最常见于中枢神经系统(CNS),而中枢神经系统的感染与神经功能损害有关。已有研究表明,干扰素耐药表型在传播过程中具有选择性优势,但其潜在机制尚不清楚。在未经治疗的感染期间,HIV-1在体液/抗体反应和CD8+ t细胞杀伤的选择性压力下进化。足够有效的抗病毒治疗可以抑制病毒复制,但如果抗病毒药物不足以阻止复制,那么正在复制的病毒就会进化出耐药性。HIV-1表型与治疗努力、临床结果、疫苗研究和治愈策略高度相关。因此,了解驱动这些表型的宿主环境动力学以及它们如何影响HIV-1发病机制至关重要。这篇综述将提供HIV-1的进入和传播以及耐药表型的全面讨论。最后,我们将评估以前和当前研究中用于表征这些表型的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信